Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine for Heart Rate Control in Sepsis and Septic Shock
NCT06742164Not yet recruiting
- Sponsor
- Ain Shams University
- Start
- Dec 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of ivabradine in sepsis and septic shock (2 arms), sponsored by Ain Shams University. Primary endpoint: Percentage of patients with heart rate reduction of at least 10 beats/min at 72 hours. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
ivabradine
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT06742164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06742164.